These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 28691382

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
    Sheftell FD, Feleppa M, Tepper SJ, Volcy M, Rapoport AM, Bigal ME.
    Headache; 2004; 44(7):661-8. PubMed ID: 15209687
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients.
    Tepper S, Allen C, Sanders D, Greene A, Boccuzzi S.
    Headache; 2003 Jan; 43(1):44-8. PubMed ID: 12864757
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA.
    Runken MC, Goodwin B, Shah M, Eaddy M, D'Souza A, Bowers B, Bell CF.
    Appl Health Econ Health Policy; 2015 Feb; 13(1):109-20. PubMed ID: 25294555
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Trends in Triptan Usage in Korea: A Population-Based Cohort Study.
    Ha WS, Jeong J, Song S, Yum J, Chu MK.
    J Korean Med Sci; 2024 Aug 12; 39(31):e222. PubMed ID: 39137809
    [Abstract] [Full Text] [Related]

  • 15. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
    Ferrari MD, Roon KI, Lipton RB, Goadsby PJ.
    Lancet; 2001 Nov 17; 358(9294):1668-75. PubMed ID: 11728541
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat.
    Mullins CD, Weis KA, Perfetto EM, Subedi PR, Healey PJ.
    J Manag Care Pharm; 2005 Jun 17; 11(5):394-402. PubMed ID: 15934798
    [Abstract] [Full Text] [Related]

  • 19. The use of triptans for pediatric migraines.
    Eiland LS, Hunt MO.
    Paediatr Drugs; 2010 Dec 01; 12(6):379-89. PubMed ID: 21028917
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.